BayardM.,HoltJ,BoroughsE., 2006.Nonalcoholic fatty liver disease,American Family Physician 73 1961 -68
RinellaME, 2015.Nonalcoholic Fatty Liver Disease, a systemic review,JAMA 313 2263 -73
KangH,JollK,JasonT,LauraFW,HariS., 2006.Metabolic syndrome is associated with greater histologic severity, higher carbohydrate and lower fat diet in patients with non-alcoholic fatty liver disease,Am J Gastroenterol 101 2247 -53
Angulo P. GI, 2007.Epidemiology: Nonalcoholic fatty liver disease,Aliment Pharmacol Ther 25 883 -9
Maxine A Papadakis , Stephen J Mcphee,Michael WRabow. Current Medical,Diagnosis, 2017.Treatment, Fifty sixth edition,Mc Graw Hil 56 697 -9
BruntEM, 2004.Non-alcoholic steatohepatitis,Semin Liver Dis 24 3 -20
FabbriniE,SullivanS,KleinS. Obesity, 2010.and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications,Hepatology 51 679 -89
2006.Non-alcoholic fatty liver disease: natural history, pathogenesis and treatment:,Br J Diabetes Vasc Dis 6 251 -60
RectorRA,JohnPT,YangzhongW,IbdahJA, 2008.Non-alcoholic fatty liver disease and metabolic syndrome: an update,World J Gastroenterol 14 185 -92
QariFA,AiGhamdi A, 2005.Fatty liver in overweight and obese patients in Western part of Saudi Arabia: a study of sonological prevalence,Pak J Med Sci 21 143 -7
AdamLA,AnguloP, 2006.Treatment of non-alcoholic fatty liver disease,Postgrad Med J 82 315 -22
LuxmiRA,SattarRA,JamalA, 2008.Association of non-alcoholic fatty liver with type 2 diabetes mellitus,J Liaqat Uni Med Health 7 188 -93
MyersPR, 2009.Noninvasive diagnosis of nonalcoholic fatty liver disease,Ann Hepatol 8 S25 -S32
SaadehS,YounossiZM,RemerEM,GramlichT,OngJP,HurleyM,MullenKD,CooperJN,Sheridan MJ, 2002.The utility of radiological imaging in nonalcoholic fatty liver disease,Gastroenterology 123 745 -50
ParkSH,KimPN,KimKW,LeeSW,YoonSE,ParkSW, 2006.Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment,Radiology 239 105 -12
PaschosP,PaletasK., 2009.Non alcoholic fatty liver disease and metabolic syndrome,Hippokratia 13 9 -19
SaleemI., .Trends of Nonalcoholic Fatty liver Diseases patients in north of Pakistan,J Med Sci;25 344 -349
FanJG,SaibaraT,ChitturiS,KimBi,SungJJ, Chut19., -
taputti A, 2007.What are the risk factors and settings for non-alcoholic fatty liver disease in Asia Pacific,J Gastroenterol Hepatol 22 794 -800
TargerG,BertoliniL,PadovaniR,RodellaS,TessariR,ZenariL, 2007.Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients,Diabetes Care 30 1212 -18
FerreiraVS,PemambucoRB,LopesE P,MoraisCN,RodriguesMC,ArudaMJ, 2010.Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus,Arq Bras Endocrinol Metab 54 362 -8
Preiss D., 2008.Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations,Clinical Science 115 141 -150
BellentaniS,BedogniG,MiglioliL,TiribelliC., 2004.The epidemiology of fatty liver,Eur J Gastroenterol Hepatol 16 1087 -93
FracanzaniAL,ValentiL,BugianesiE,AndreolettiM,ColliA,VanniE, 2008.Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes,Hepatology 48 792 -8
CortrimHP,PraiseER,OliveiraCP,LeiteN,MartinelliA,GalliziJ, 2011.Non alcohol fatty liver disease in Brazil. Clinical and histological profile,Ann Hepatol 10 33 -7
LeiteNC,SallesGF,AraujoAL,Villela-NogueiraCA,CardosoCR, 2009.Prevalence and associated factors of non-alcoholic fatty liver disease in patients with Type2 diabetes mellitus,Liver Int 2 113 -9